252 related articles for article (PubMed ID: 28233900)
21. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
[TBL] [Abstract][Full Text] [Related]
22. [Use of whole-body diffusion-weighted magnetic resonance imaging for the diagnosis of and therapeutic response in multiple myeloma].
Puskás T; Henits I
Orv Hetil; 2014 Aug; 155(31):1241-5. PubMed ID: 25095285
[TBL] [Abstract][Full Text] [Related]
23. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
24. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.
Baur-Melnyk A; Buhmann S; Becker C; Schoenberg SO; Lang N; Bartl R; Reiser MF
AJR Am J Roentgenol; 2008 Apr; 190(4):1097-104. PubMed ID: 18356461
[TBL] [Abstract][Full Text] [Related]
25. Imaging findings and clinical features of patients with multiple myeloma with the prognostic effect of bone marrow focal and diffuse infiltration patterns on spine MRI.
Aribas BK; Arda K; Yologlu Z; Ciledag N; Aktas E; Ozdemir S; Dogan K; Fen T; Dagli M
Minerva Med; 2011 Apr; 102(2):115-24. PubMed ID: 21483398
[TBL] [Abstract][Full Text] [Related]
26. [Bone disease in multiple myeloma. A study of 237 cases].
Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
[TBL] [Abstract][Full Text] [Related]
27. Automated "Bone Subtraction" Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma.
Horger M; Ditt H; Liao S; Weisel K; Fritz J; Thaiss WM; Kaufmann S; Nikolaou K; Kloth C
Acad Radiol; 2017 May; 24(5):623-632. PubMed ID: 28256439
[TBL] [Abstract][Full Text] [Related]
28. Whole-body ultra-low dose CT using spectral shaping for detection of osteolytic lesion in multiple myeloma.
Suntharalingam S; Mikat C; Wetter A; Guberina N; Salem A; Heil P; Forsting M; Nassenstein K
Eur Radiol; 2018 Jun; 28(6):2273-2280. PubMed ID: 29322333
[TBL] [Abstract][Full Text] [Related]
29. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
[TBL] [Abstract][Full Text] [Related]
31. Whole-body low-dose computed tomography (WBLDCT) in staging and re-staging of multiple myeloma.
Ippolito D; Giandola T; Maino C; Pecorelli A; Ragusi M; Porta M; Gandola D; Franzesi CT; Sironi S
Ann Hematol; 2021 May; 100(5):1241-1249. PubMed ID: 33660034
[TBL] [Abstract][Full Text] [Related]
32. Current role of CT and whole body MRI in multiple myeloma.
Duvauferrier R; Valence M; Patrat-Delon S; Brillet E; Niederberger E; Marchand A; Rescan M; Guillin R; Decaux O
Diagn Interv Imaging; 2013 Feb; 94(2):169-83. PubMed ID: 23298944
[TBL] [Abstract][Full Text] [Related]
33. Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques.
Rubini G; Niccoli-Asabella A; Ferrari C; Racanelli V; Maggialetti N; Dammacco F
Crit Rev Oncol Hematol; 2016 May; 101():169-83. PubMed ID: 26997302
[TBL] [Abstract][Full Text] [Related]
34. Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.
Okasaki M; Kubota K; Minamimoto R; Miyata Y; Morooka M; Ito K; Ishiwata K; Toyohara J; Inoue T; Hirai R; Hagiwara S; Miwa A
Ann Nucl Med; 2015 Apr; 29(3):224-32. PubMed ID: 25421383
[TBL] [Abstract][Full Text] [Related]
35. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
Sommer G; Klarhöfer M; Lenz C; Scheffler K; Bongartz G; Winter L
Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
[TBL] [Abstract][Full Text] [Related]
36. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
[TBL] [Abstract][Full Text] [Related]
37. Whole-body imaging of bone marrow.
Schmidt GP; Reiser MF; Baur-Melnyk A
Semin Musculoskelet Radiol; 2009 Jun; 13(2):120-33. PubMed ID: 19455475
[TBL] [Abstract][Full Text] [Related]
38. Integrated Shimming Improves Lesion Detection in Whole-Body Diffusion-Weighted Examinations of Patients With Plasma Disorder at 3 T.
Zhang H; Xue H; Alto S; Hui L; Kannengiesser S; Berthold K; Jin Z
Invest Radiol; 2016 May; 51(5):297-305. PubMed ID: 26704452
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Staudenherz A; Senn D; Raderer M; Weber M; Simonitsch-Klupp I; Mayerhoefer ME
PLoS One; 2016; 11(10):e0164118. PubMed ID: 27723817
[TBL] [Abstract][Full Text] [Related]
40. Rapid study assessment in follow-up whole-body computed tomography in patients with multiple myeloma using a dedicated bone subtraction software.
Sieren MM; Brenne F; Hering A; Kienapfel H; Gebauer N; Oechtering TH; Fürschke A; Wegner F; Stahlberg E; Heldmann S; Barkhausen J; Frydrychowicz A
Eur Radiol; 2020 Jun; 30(6):3198-3209. PubMed ID: 32048038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]